Abstract
Invention relates to oncological examinations in gynaecology. Human epidydimis secretory protein 4 is suggested to be used as an indicator in assessment of cancer risk in patients with adnexal neoformations.
| Translated title of the contribution | Olnīcu vēža riska noteikšanas paņēmiens sievietēm ar veidojumu dzemdes piedēkļu rajonā |
|---|---|
| Original language | Latvian |
| Patent number | 14703 |
| IPC | G01N33/53 |
| Priority date | 2/05/13 |
| Filing date | 2/05/13 |
| Publication status | Published - 20 Dec 2013 |
Keywords*
- assessment of ovarian cancer risk
Field of Science*
- 3.2 Clinical medicine
Patent expiration date
- 01.12.2020
